- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0005114

Anzalp Pharmasolutions Private Limited
About Anzalp Pharmasolutions Private Limited
Data last updated:
Anzalp Pharmasolutions Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24200MP2020PTC051303.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Akshay N Patel and Gita Ben Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 37 Rambali Nagar, Indore, Madhya Pradesh, India – 452006.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.93 Lakh, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹13.43 Lakh and EBITDA of -₹13.43 Lakh.
Anzalp Pharmasolutions Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0005114).
Company details
Recognitions & Rankings of Anzalp Pharmasolutions
Contact details
Anzalp Pharmasolutions Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered Address37 Rambali Nagar, Indore, Madhya Pradesh, India – 452006
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anzalp Pharmasolutions is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anzalp Pharmasolutions Private Limited, buy the company report.
Financials of Anzalp Pharmasolutions Private Limited
FY 2025 filings availableAnzalp Pharmasolutions Private Limited reported revenue of ₹1.93 Lakh (down 85% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹13.43 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹13.43 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Anzalp Pharmasolutions Private Limited, buy the company report.
Board of directors of Anzalp Pharmasolutions Private Limited
Anzalp Pharmasolutions has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshay N Patel Also directs: Anzalp Herbal Products Private Limited, Hari Om Greenery Private Limited, Neo Crops Private Limited and 5 more | Director | 01 May 2020 | 6 Years 5 Months | Current |
| Gita Ben Patel Also directs: Anzalp Herbal Products Private Limited | Director | 01 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Anzalp Pharmasolutions Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Captain Gypsum & Frame's Private Limited | ₹1.94 Lakh (FY 2024) | 69.0% | Mumbai, Maharashtra, India | |||
| Metgene Life Sciences Private Limited | ₹1.93 Lakh (FY 2024) | Ludhiana, Punjab, India | ||||
| Chemizol Lubricants Private Limited | ₹1.93 Lakh (FY 2016) | 71.0% | Bengaluru, Karnataka, India | |||
| Geetanjali Worklabs Private Limited | ₹1.93 Lakh (FY 2025) | 99.0% | Amravati, Maharashtra, India | |||
| Bhikha Laboratories Private Limited | ₹1.93 Lakh (FY 2021) | -45.0% | Ghaziabad, Uttar Pradesh, India | |||
| Anzalp Pharmasolutions Private Limitedthis company | ₹1.93 Lakh (FY 2024) | -₹13.43 Lakh | -85.0% | Indore, Madhya Pradesh, India | ||
| Indira Priyadarshini Industries Private Limited | ₹1.92 Lakh (FY 2025) | 27.0% | Ibrahimpatnam, Telangana, India | |||
| Jainti Pharmaceuticals Private Limited | ₹1.92 Lakh (FY 2025) | -55.0% | Varanasi, Uttar Pradesh, India | |||
| Emsons Organics Limited | ₹1.92 Lakh (FY 2016) | -26.0% | Rajpura, Punjab, India | |||
| Toricca Cosmetics Private Limited | ₹1.91 Lakh (FY 2025) | 27.0% | Rajkot, Gujarat, India | |||
| Chemnex Lifesciences Private Limited | ₹1.91 Lakh (FY 2023) | -36.0% | Borivali, Mumbai, Maharashtra, India |
To see the full peer comparison of Anzalp Pharmasolutions Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Anzalp Pharmasolutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anzalp Pharmasolutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Anzalp Pharmasolutions Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Anzalp Pharmasolutions Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Akshay N Patel was appointed as Director on 01 May 2020.
Frequently asked questions
Anzalp Pharmasolutions is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 May 2020 (6+ years old) and is registered under CIN U24200MP2020PTC051303.
Anzalp Pharmasolutions has 2 current directors:
- Akshay N Patel - Director
- Gita Ben Patel - Director
The latest financial statements of Anzalp Pharmasolutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Anzalp Pharmasolutions is U24200MP2020PTC051303. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anzalp Pharmasolutions was incorporated on 01 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Anzalp Pharmasolutions by revenue are Captain Gypsum & Frame's Private Limited, Metgene Life Sciences Private Limited, Chemizol Lubricants Private Limited, Geetanjali Worklabs Private Limited, Bhikha Laboratories Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Akshay N Patel was appointed as Director on 01 May 2020. Gita Ben Patel was appointed as Director on 01 May 2020.
Yes, Anzalp Pharmasolutions is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0005114).
The registered office of Anzalp Pharmasolutions is at 37 Rambali Nagar, Indore, Madhya Pradesh, India – 452006.
Anzalp Pharmasolutions operates in the pharma industry, in the drug formulation and development segment.
Anzalp Pharmasolutions can be reached at its registered office: 37 Rambali Nagar, Indore, Madhya Pradesh, India – 452006.